Glucagon-like peptide 1 receptor agonists GLP1-RAs promote glucose-dependent insulin secretion and decrease glucagon secretion, providing glycaemic benefits
Toschi A, Edelstein J, Rockwell P, Ohh M, Foster DA
Others being discussed during the two-day meeting include TB-500 (touted for wound healing) and epitalon (ostensibly a hack for insomnia)
In CRC, overexpression of glucose transporters and key glycolytic enzymes drives the Warburg effect, resulting in accelerated glycolytic flux
Cardiovascular Health: Several GLP-1 agonists have been shown to reduce the risk of heart disease, supporting long-term vitality
The biggest cost drivers are prescription pricing, lab repetition, and extra follow-ups during dose titration, so a low advertised rate can rise quickly once add-ons and testing are included